Pharmaceutical composition capable of the incorporation of lenalidomide in various crystalline modifications

Pharmaceutical composition capable of the incorporation of lenalidomide in various crystalline modifications

The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide cocrystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distributi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Merkys, Kestutis, Konosonoks, Armands
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Merkys, Kestutis
Konosonoks, Armands
description The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide cocrystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distribution (d90) ranging from 1 μm to 100 μm.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US10987344B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US10987344B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US10987344B23</originalsourceid><addsrcrecordid>eNqNjsEKwjAQRHvxIOo_rB8gqC1Yr4riUVDPZU03dGGTDUkq-Pe24gd4Gpg3M8y0kGuH0aGhPrNBAaMuaOLM6sFgwKcQqIXcEbA3GoNG_MLBFPIo3KrjdqTwwsjaJzDxnTKKsCdw2rIdlsdOmhcTi5Jo8dNZsTyf7sfLioI2lMJww1NuHrfNel_vyqo6bMt_Mh_b70Na</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical composition capable of the incorporation of lenalidomide in various crystalline modifications</title><source>esp@cenet</source><creator>Merkys, Kestutis ; Konosonoks, Armands</creator><creatorcontrib>Merkys, Kestutis ; Konosonoks, Armands</creatorcontrib><description>The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide cocrystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distribution (d90) ranging from 1 μm to 100 μm.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210427&amp;DB=EPODOC&amp;CC=US&amp;NR=10987344B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210427&amp;DB=EPODOC&amp;CC=US&amp;NR=10987344B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Merkys, Kestutis</creatorcontrib><creatorcontrib>Konosonoks, Armands</creatorcontrib><title>Pharmaceutical composition capable of the incorporation of lenalidomide in various crystalline modifications</title><description>The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide cocrystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distribution (d90) ranging from 1 μm to 100 μm.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjsEKwjAQRHvxIOo_rB8gqC1Yr4riUVDPZU03dGGTDUkq-Pe24gd4Gpg3M8y0kGuH0aGhPrNBAaMuaOLM6sFgwKcQqIXcEbA3GoNG_MLBFPIo3KrjdqTwwsjaJzDxnTKKsCdw2rIdlsdOmhcTi5Jo8dNZsTyf7sfLioI2lMJww1NuHrfNel_vyqo6bMt_Mh_b70Na</recordid><startdate>20210427</startdate><enddate>20210427</enddate><creator>Merkys, Kestutis</creator><creator>Konosonoks, Armands</creator><scope>EVB</scope></search><sort><creationdate>20210427</creationdate><title>Pharmaceutical composition capable of the incorporation of lenalidomide in various crystalline modifications</title><author>Merkys, Kestutis ; Konosonoks, Armands</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US10987344B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Merkys, Kestutis</creatorcontrib><creatorcontrib>Konosonoks, Armands</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Merkys, Kestutis</au><au>Konosonoks, Armands</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical composition capable of the incorporation of lenalidomide in various crystalline modifications</title><date>2021-04-27</date><risdate>2021</risdate><abstract>The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide cocrystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distribution (d90) ranging from 1 μm to 100 μm.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US10987344B2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Pharmaceutical composition capable of the incorporation of lenalidomide in various crystalline modifications
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A27%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Merkys,%20Kestutis&rft.date=2021-04-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS10987344B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true